Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Determination of metronidazole and its two major metabolites in biological fluids by high pressure liquid chromatography.

Literature DB >> 728287

Determination of metronidazole and its two major metabolites in biological fluids by high pressure liquid chromatography.

A Gulaid, G W Houghton, O R Lewellen, J Smith, P S Thorne.

Abstract

Entities: Chemical

Mesh：

Substances：
Metronidazole

Year: 1978 PMID： 728287 PMCID： PMC1429550 DOI： 10.1111/j.1365-2125.1978.tb04608.x

Source DB: PubMed Journal: Br J Clin Pharmacol ISSN： 0306-5251 Impact factor: 4.335

× No keyword cloud information.

5 in total

1. GLC analysis of metronidazole in human plasma.

Authors: N F Wood
Journal: J Pharm Sci Date: 1975-06 Impact factor: 3.534

2. Microbiological agar diffusion assay for metronidazole concentrations in serum.

Authors: M E Levison
Journal: Antimicrob Agents Chemother Date: 1974-05 Impact factor: 5.191

3. Determination of therapeutic levels of metronidazole in plasma by gas-liquid chromatography.

Authors: K K Midha; I J McGilveray; J K Cooper
Journal: J Chromatogr Date: 1973-12-19

4. The isolation and identification of the urinary oxidative metabolites of metronidazole in man.

Authors: J E Stambaugh; L G Feo; R W Manthei
Journal: J Pharmacol Exp Ther Date: 1968-06 Impact factor: 4.030

5. Use of high-pressure liquid chromatography to determine plasma levels of metronidazole and metabolites after intravenous administration.

Authors: L A Wheeler; M De Meo; M Halula; L George; P Heseltine
Journal: Antimicrob Agents Chemother Date: 1978-02 Impact factor: 5.191

5 in total

17 in total

1. In vitro susceptibilities of Actinobacillus actinomycetemcomitans to a number of antimicrobial combinations.

Authors: M J Pavicić; A J van Winkelhoff; J de Graaff
Journal: Antimicrob Agents Chemother Date: 1992-12 Impact factor: 5.191

2. Synergistic effects between amoxicillin, metronidazole, and the hydroxymetabolite of metronidazole against Actinobacillus actinomycetemcomitans.

Authors: M J Pavicić; A J van Winkelhoff; J de Graaff
Journal: Antimicrob Agents Chemother Date: 1991-05 Impact factor: 5.191

3. Disposition of metronidazole and its effects on sulphasalazine metabolism in patients with inflammatory bowel disease.

Authors: J L Shaffer; A Kershaw; J B Houston
Journal: Br J Clin Pharmacol Date: 1986-04 Impact factor: 4.335

Review 4. Clinical pharmacokinetics of metronidazole.

Authors: E D Ralph
Journal: Clin Pharmacokinet Date: 1983 Jan-Feb Impact factor: 6.447

5. Capillary agar diffusion assay for measuring metronidazole in human gingival crevice fluid.

Authors: F Notten; A Koek-Van Oosten; F Mikx
Journal: Antimicrob Agents Chemother Date: 1982-05 Impact factor: 5.191

6. A comparison of the pharmacokinetics of metronidazole in man after oral administration of single doses of benzoylmetronidazole and metronidazole.

Authors: G W Houghton; H K Hundt; F O Muller; R Templeton
Journal: Br J Clin Pharmacol Date: 1982-08 Impact factor: 4.335

7. A rapid and specific semi-micro method involving high-pressure liquid chromatography for the assay of metronidazole in plasma, saliva, serum, urine and whole blood.

Authors: C M Kaye; M G Sankey; L A Thomas
Journal: Br J Clin Pharmacol Date: 1980-05 Impact factor: 4.335